Telomir Pharmaceuticals, Inc. Signs Media Deal with New to The Street for Network Interview Broadcasts, Billboards, and TV Commercial Support

New to The Street televised business show will feature Telomir Pharmaceuticals, Inc. (NASDAQ: TELO) ($TELO) ("Company"), a pre-clinical stage pharmaceutical company, focused on its TELOMIR-1 drug that could reverse age-related common diseases - https://telomirpharma.com/ & https://newtothestreet.com/

Telomir Pharmaceuticals, Inc. Signs Media Deal with New to The Street for Network Interview Broadcasts, Billboards, and TV Commercial Support

Format

Source

Downloads